What evidence describes clear cell adenocarcinoma of the omentum or other extra-ovarian sites arising after bladder urothelial/transitional cell carcinoma or endometriosis, and what pathological evidence supports each proposed origin?

Tripdatabase
2026 · doi:10.5281/zenodo.23080964 · W7215116195
OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-04 ⓘ

This paper reviews evidence linking clear cell adenocarcinoma of the omentum to endometriosis through case reports, while noting that data connecting bladder urothelial carcinoma to this cancer remain limited.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-04 · read from full text ⓘ

This paper reviews the limited indirect evidence linking clear cell adenocarcinoma of the omentum or extra-ovarian sites to prior bladder urothelial carcinoma or endometriosis. It examines pathological evidence supporting proposed origins, noting that existing data primarily highlight endometrial transformation in cases associated with endometriosis. The authors emphasize that further research is required to clarify the links between bladder urothelial carcinoma and these extra-ovarian tumors. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Limited indirect evidence links clear cell adenocarcinoma to endometriosis, with case reports highlighting endometrial transformation. Further research is required to explore links between bladder urothelial carcinoma and extra-ovarian clear cell adenocarcinoma, as existing data primarily address endometriosis-related origins.
Full text 803 characters · extracted from oa-doi-fallback · click to expand
Published October 1, 2026 | Version v1 Other Open What evidence describes clear cell adenocarcinoma of the omentum or other extra-ovarian sites arising after bladder urothelial/transitional cell carcinoma or endometriosis, and what pathological evidence supports each proposed origin? Description Limited indirect evidence links clear cell adenocarcinoma to endometriosis, with case reports highlighting endometrial transformation. Further research is required to explore links between bladder urothelial carcinoma and extra-ovarian clear cell adenocarcinoma, as existing data primarily address endometriosis-related origins. Files 969d7b4e-b9c2-4e19-862d-654c3c12f48f.pdf Files (18.6 kB) | Name | Size | Download all | |---|---|---| | md5:9a7829002bd543dd39792f19d35d70ca | 18.6 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-06T06:07:52.081803+00:00
License: CC0 · commercial use OK